tamoxifen "copyfarm" 20 mg filmovertrukne tabletter
orifarm generics a/s - tamoxifencitrat - filmovertrukne tabletter - 20 mg
tamoxifen "sandoz" 20 mg filmovertrukne tabletter
sandoz a/s - tamoxifencitrat - filmovertrukne tabletter - 20 mg
tamoxifen "sandoz" 10 mg filmovertrukne tabletter
sandoz a/s - tamoxifencitrat - filmovertrukne tabletter - 10 mg
tamoxifen "sandoz" 30 mg filmovertrukne tabletter
sandoz a/s - tamoxifencitrat - filmovertrukne tabletter - 30 mg
tamoxifen "mylan" 10 mg tabletter
mylan ab - tamoxifen - tabletter - 10 mg
tamoxifen "mylan" 20 mg tabletter
mylan ab - tamoxifen - tabletter - 20 mg
tamoxifen "orifarm" 20 mg tabletter
orifarm generics a/s - tamoxifen - tabletter - 20 mg
verzenios
eli lilly nederland b.v. - abemaciclib - bryst neoplasmer - antineoplastiske midler - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.
aromasin 25 mg overtrukne tabletter
pfizer aps - exemestan - overtrukne tabletter - 25 mg
exemestan "accord" 25 mg filmovertrukne tabletter
accord healthcare b.v. - exemestan - filmovertrukne tabletter - 25 mg